Fresenius reports 80% of its patients on home dialysis utilize connected health platform
Click Here to Manage Email Alerts
Fresenius Medical North America reports growth in the number of patients on home hemodialysis who utilize the company’s connected health platform, with adoption increasing more than 44% in the past year, according to a press release.
The platform is a companion to Fresenius’s NxStage home hemodialysis machines which, the release noted, are the “first and only truly portable hemodialysis systems cleared for home use in the United States.”
"This is a major milestone for our Nx2me Connected Health platform and reflects our efforts to make home dialysis easier than before," Joe Turk, president of FMCNA's renal therapies group, said in the release. "We know that when patients use our connected health platforms, we see higher engagement and patient retention. This technology is an essential component to enabling even more patients with kidney failure to live the fullest life possible."
According to the release, the Nx2me Connected Health platform assists with virtual sessions and consists of Bluetooth technology that allows for the sharing of information between patients and clinicians (this includes data from the home hemodialysis cycler, such as weight, blood pressure and temperature).
Further, the release noted the platform has demonstrated efficacy in lowering home therapy discontinuation (by 29%) and increasing the likelihood of patients completing their home training program (by 39%).
Marty Schreiber, MD, chief medical officer for home treatments at DaVita, also commented on how the platform can improve care.
“Ensuring our patients have the most innovative, inclusive home technology available is paramount to increasing access and improving health equity in home dialysis,” he said. "Nx2me's intuitive interface makes it easy for patients to treat safely — and confidently — at home, while giving our care teams timely data for proactive care planning to help improve outcomes and patients' overall quality of life."